Science and research will be held up as part of the solution to economic malaise at next week’s EU summit, where there is one broad topic on the agenda: the economic downturn.
President Obama’s move to focus on “science as economic saviour” may have stalled. But there is still optimism about the impact the new administration will have.
The pipeline of drugs in development in French biotechs saw a significant increase in 2008, but the funding climate may undermine this advance, says France Biotech.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.